col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


104 Results       Page 1

 [1] 
Springer-Verlag: Inflammopharmacology
  original article Date Title Authors   All Authors
1 [GO] 2024―May―21 Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols Abdul Mannan Baig, Sandy Rosko, Beate Jaeger, Joachim Gerlach, Hans Rausch
2 [GO] 2024―May―19 Surveying haemoperfusion impact on COVID-19 from machine learning using Shapley values Behzad Einollahi, Mohammad Javanbakht, Mehrdad Ebrahimi, Mohammad Ahmadi, Morteza Izadi, Sholeh Ghasemi, et al. (+4)
3 [GO] 2024―May―02 Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study Almudena Rodríguez-Fernández, Irene Visos-Varela, Maruxa Zapata-Cachafeiro, Samuel Pintos-Rodríguez, Rosa M. García-Álvarez, Teresa M. Herdeiro, et al. (+17)
4 [GO] 2024―Apr―15 Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient Rosa María García-Álvarez, Maruxa Zapata-Cachafeiro, Irene Visos-Varela, Almudena Rodríguez-Fernández, Samuel Pintos-Rodríguez, Maria Piñeiro-Lamas, et al. (+12)
5 [GO] 2024―Mar―16 Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19 Seyma Oncu, Derya Korkmaz
6 [GO] 2024―Jan―31 Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach Mina T. Kelleni
7 [GO] 2023―Dec―20 Mesenchymal stem cell therapy for COVID-19 infection Seyyed Mohammad Matin Alavi-Dana, Yazdan Gholami, Mohammadreza Meghdadi, Mohammad Saleh Fadaei, Vahid Reza Askari
8 [GO] 2023―Dec―14 Intravenous immunoglobulin for treatment of hospitalized COVID-19 patients: an evidence mapping and meta-analysis Mei-xuan Li, Yan-fei Li, Xin Xing, Jun-qiang Niu, Liang Yao, Meng-ying Lu, et al. (+15)
9 [GO] 2023―Nov―27 Therapeutic potential and possible mechanisms of ginseng for depression associated with COVID-19 Fangyi Zhao, Kai Zhang, Hongyu Chen, Tianqi Zhang, Jiayu Zhao, Qianyu Lv, et al. (+4)
10 [GO] 2023―Nov―13 Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy Adel A. Gomaa, Yasmin A. Abdel-Wadood, Romany H. Thabet, Ghada A. Gomaa
11 [GO] 2023―Oct―17 Efficacy and safety of licorice (Glycyrrhiza glabra) in moderately ill patients with COVID-19: a randomized controlled trial Ali Ameri, Mehdi Farashahinejad, Parivash Davoodian, Omid Safa, Amin Kusha, Habib Dadvand, et al. (+2)
12 [GO] 2023―Oct―17 The effect of probiotics on the risk of mortality in patients with COVID-19: systematic review and meta-analysis of randomized trials Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
13 [GO] 2023―Oct―16 The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression Arto Yuwono Soeroto, Hendarsyah Suryadinata, Theo Audi Yanto, Timotius Ivan Hariyanto
14 [GO] 2023―Oct―13 Cytokine profiles in COVID-19 patients undergoing adjunct ozone therapy: some comments Salvatore Chirumbolo, Sergio Pandolfi, Marianno Franzini, Luigi Valdenassi
15 [GO] 2023―Oct―09 Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies Zahra Shafaghat, Amir-Hossein Khosrozadeh Ghomi, Hossein Khorramdelazad, Elaheh Safari
16 [GO] 2023―Oct―07 Systematic review and meta-analysis of anti-CD20 treatments in patients with COVID-19: an assessment of severe illness and mortality outcomes Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam
17 [GO] 2023―Sep―29 Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers Pavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi
18 [GO] 2023―Aug―21 Ibuprofen, other NSAIDs and COVID-19: a narrative review William Laughey, Imran Lodhi, Graham Pennick, Lucinda Smart, Olutoba Sanni, Suneet Sandhu, Bruce Charlesworth
19 [GO] 2023―Aug―07 Combined systemic inflammatory indexes as reflectors of outcome in patients with COVID-19 infection admitted to ICU Amir Tahavvori, Reza Mosaddeghi-Heris, Faezeh Ghanbari Sevari, Seyed Mohammad Amin Alavi, Peghah Panahi, Niloufar Abbasi, et al. (+2)
20 [GO] 2023―Jul―17 Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID Tamás Constantin, Tamás Pék, Zsuzsanna Horváth, Diána Garan, Attila J. Szabó
21 [GO] 2023―Jul―15 Effect of treatment regimen of the rheumatoid arthritis patients on the risk of coronavirus disease 2019 by modulating the inflammatory mediators Zahra Bagheri-Hosseinabadi, Alireza Dehghani, Mohammad Amin Lotfi, Mitra Abbasifard
22 [GO] 2023―Jul―12 Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement Hadi Esmaeili Gouvarchin Ghaleh, Morteza Izadi, Mohammad Javanbakht, Mostafa Ghanei, Behzad Einollahi, Nematollah Jonaidi Jafari, et al. (+11)
23 [GO] 2023―Jun―21 Long COVID and possible preventive options Szilvia Sebők, Klara Gyires
24 [GO] 2023―Jun―16 The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one Mina T. Kelleni
25 [GO] 2023―Jun―02 Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
26 [GO] 2023―Jun―01 Nutritional deficiencies and long COVID: correspondence Amnuay Kleebayoon, Viroj Wiwanitkit
27 [GO] 2023―May―19 Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Nada A. Ashour, Walaa A. Negm
28 [GO] 2023―May―15 The post-COVID stress syndrome: from the three-stage stress response of Hans Selye to COVID-19 Sandor Szabo
29 [GO] 2023―Apr―20 Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami Yasamin Sharbatdar, Ronak Mousavian, Seyed Mostafa Noorbakhsh Varnosfaderani, Fatemeh Aziziyan, Mahsa Liaghat, Payam Baziyar, et al. (+6)
30 [GO] 2023―Apr―18 The effect of vitamin C on the risk of mortality in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Chia Siang Kow, Syed Shahzad Hasan, Dinesh Sangarran Ramachandram
31 [GO] 2023―Apr―10 Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19 Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
32 [GO] 2023―Apr―05 Fatigue, sleepiness and sleep quality are SARS-CoV-2 variant independent in patients with long COVID symptoms Anna Reka Percze, Alexandra Nagy, Lorinc Polivka, Eniko Barczi, Ibolya Czaller, Zsuzsanna Kovats, et al. (+4)
33 [GO] 2023―Mar―26 Real-world practice of the Egyptian Kelleni’s protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol Mina T. Kelleni
34 [GO] 2023―Mar―25 What is the role of brown adipose tissue in metabolic health: lessons learned and future perspectives in the long COVID? Iryna Muzyka, Oleh Revenko, Iryna Kovalchuk, Maryanna Savytska, Anna Bekesevych, Roksolana Kasko, Oksana Zayachkivska
35 [GO] 2023―Mar―24 Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease Dorottya Fesu, Lorinc Polivka, Eniko Barczi, Marcell Foldesi, Gabor Horvath, Edit Hidvegi, et al. (+2)
36 [GO] 2023―Mar―22 Long COVID prevalence and physiology-centered risks: population-based study in Ukraine Iryna Muzyka, Mariana Yakhnytska, Maryana Savytska, Oksana Zayachkivska
37 [GO] 2023―Mar―21 What is the role of brown adipose tissue in metabolic health: lessons learned and future perspectives in the long COVID? Iryna Muzyka, Oleh Revenko, Iryna Kovalchuk, Maryanna Savytska, Anna Bekesevych, Oksana Zayachkivska
38 [GO] 2023―Mar―15 Nutritional deficiencies that may predispose to long COVID John V. Schloss
39 [GO] 2023―Mar―09 COVID-19-induced neurological symptoms: focus on the role of metal ions Yi-Yue Zhang, Kai-Di Ren, Xiu-Ju Luo, Jun Peng
40 [GO] 2023―Feb―27 Could the fibromyalgia syndrome be triggered or enhanced by COVID-19? Maria Fernanda Pessano Fialho, Evelyne Silva Brum, Sara Marchesan Oliveira
41 [GO] 2023―Feb―01 The direct correlation between microbiota and SARS-CoV-2 infectious disease Antonio Vitiello, Francesco Ferrara, Andrea Zovi
42 [GO] 2023―Jan―27 High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single center Murat Bektaş, Servet Yüce, Mustafa Ay, Muhammed Hamdi Uyar, Mustafa Erkut Önder, Muhammed İkbal Kılıç
43 [GO] 2023―Jan―07 A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective? Mohsen Nabi-Afjadi, Fatemeh Mohebi, Hamidreza Zalpoor, Fatemeh Aziziyan, Abdullatif Akbari, Hemen Moradi-Sardareh, et al. (+3)
44 [GO] 2023―Jan―04 Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells Babak Arjmand, Sepideh Alavi-Moghadam, Masoumeh Sarvari, Mostafa Rezaei-Tavirani, Ahmad Rezazadeh- Mafi, Rasta Arjmand, et al. (+3)
45 [GO] 2022―Dec―20 The effect of ramatroban on cytokine and thrombotic storms in Covid-19 Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Hebatallah M. Saad, Gaber El-Saber Batiha
46 [GO] 2022―Dec―09 A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Fadia S. Youssef, Suzy A. El-Sherbeni, Walaa A. Negm
47 [GO] 2022―Nov―29 Efficacy and safety of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis An-ran Xi, Yi-jun Luo, Jin-Tao Guan, Wei-Jie Wang, Zheng-Hao Xu
48 [GO] 2022―Nov―24 Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Mubarak Alruwaili, Raed AlRuwaili, Sarah M. Albogami, et al. (+3)
49 [GO] 2022―Nov―19 Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial Ali Ameri, Masoomeh Frouz Asadi, Ava Ziaei, Majid Vatankhah, Omid Safa, Manoochehr Kamali, et al. (+3)
50 [GO] 2022―Oct―25 Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines Sevilay Batıbay, Rezan Koçak Ulucaköy, Zafer Günendi, Işıl Fidan, Gülendam Bozdayı, Feride Nur Göğüş
51 [GO] 2022―Oct―02 The role of berberine in Covid-19: potential adjunct therapy Ahmad O. Babalghith, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Michel De Waard, Sadiq Mohammed Al-Hamash, Sabatier Jean-Marc, et al. (+2)
52 [GO] 2022―Sep―30 Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy? Basil Mohammed Alomair, Hayder M. Al-kuraishy, Ali K. Al-Buhadily, Ali I. Al-Gareeb, Michel De Waard, Engy Elekhnawy, Gaber El-Saber Batiha
53 [GO] 2022―Sep―22 Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild-moderate COVID-19 and prevention of post-COVID cognitive impairment Adel A. Gomaa, Yasmin A. Abdel-Wadood, Mohamed A. Gomaa
54 [GO] 2022―Sep―16 Potential role of lipoxin in the management of COVID-19: a narrative review Gaber El-Saber Batiha, Ali I. Al-Gareeb, Engy Elekhnawy, Hayder M. Al-kuraishy
55 [GO] 2022―Sep―12 Association between chemosensory dysfunctions and inflammatory biomarkers in patients with SARS-CoV-2 infection: a systematic review and meta-analysis Elisama Gomes Magalhães de Melo, Rayle Monteiro Andrade, Sara Juliana de Abreu de Vasconcellos, Priscila Lima dos Santos, Diego Moura Tanajura, Lucindo José Quintans-Júnior, et al. (+2)
56 [GO] 2022―Sep―01 Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19) Banlambhabok Khongthaw, Kanika Dulta, Pankaj Kumar Chauhan, Vinod Kumar, Joshua O. Ighalo
57 [GO] 2022―Aug―26 Dysregulation of immunity in COVID-19 and SLE Seyyed Sina Hejazian, Seyyedeh Mina Hejazian, Farahnoosh Farnood, Sima Abedi Azar
58 [GO] 2022―Aug―26 Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols Engy Elekhnawy, Walaa A. Negm, Suzy A. El-Sherbeni, Ahmed Zayed
59 [GO] 2022―Aug―22 Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways Hamidreza Zalpoor, Maryam Bakhtiyari, Hooriyeh Shapourian, Puria Rostampour, Chanour Tavakol, Mohsen Nabi-Afjadi
60 [GO] 2022―Aug―18 Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view Francesco Ferrara, Andrea Zovi, Ugo Trama, Antonio Vitiello
61 [GO] 2022―Aug―10 Pathogenic role of cytokines in COVID-19, its association with contributing co-morbidities and possible therapeutic regimens Ayesha Tanveer, Bushra Akhtar, Ali Sharif, Uzma Saleem, Azhar Rasul, Aftab Ahmad, Kashif Jilani
62 [GO] 2022―Aug―03 Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Walaa A. Negm, Athanasios Alexiou, Gaber El-Saber Batiha
63 [GO] 2022―Jul―27 Effects of Boswellia species on viral infections with particular attention to SARS-CoV-2 Zahra Jamshidi, Maryam Hashemi, Rezvan Yazdian-Robati, Leila Etemad, Zahra Salmasi, Prashant Kesharwani
64 [GO] 2022―Jul―14 Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients Habib Ghaznavi, Zahra Mohammadghasemipour, Milad Shirvaliloo, Mohammad Kazem Momeni, Malihe Metanat, Farzaneh Gorgani, et al. (+8)
65 [GO] 2022―Jun―20 Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial Mohammadreza Moslemi, Seyyedeh Mina Hejazian, Molod Shaddelan, Fatemeh Javanali, Alireza Mirghaffari, Armin Sadeghi, et al. (+5)
66 [GO] 2022―Jun―14 The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review Mohammed Ahmed Akkaif, Abubakar Sha’aban, Arturo Cesaro, Ammar Ali Saleh Jaber, Andrea Vergara, Ismaeel Yunusa, et al. (+6)
67 [GO] 2022―May―30 The key role of Calpain in COVID-19 as a therapeutic strategy Aref Doozandeh Juibari, Mohammad Hossein Rezadoost, Masoud Soleimani
68 [GO] 2022―May―30 Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications Ankita Sood, Onkar Bedi
69 [GO] 2022―May―13 COVID-19 and corticosteroids: a narrative review Gaber El-Saber Batiha, Ali I. Al-Gareeb, Hebatallah M. Saad, Hayder M. Al-kuraishy
70 [GO] 2022―May―04 COVID-19 and the role of cytokines in this disease Amin Hasanvand
71 [GO] 2022―Apr―29 A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19 Gomaa Mostafa-Hedeab, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Philippe Jeandet, Hebatallah M. Saad, Gaber El-Saber Batiha
72 [GO] 2022―Apr―26 High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Luay Alkazmi, Ola A. Habotta, Gaber El-Saber Batiha
73 [GO] 2022―Apr―07 Potential plants for inflammatory dysfunction in the SARS-CoV-2 infection Diorge Jônatas Marmitt
74 [GO] 2022―Mar―28 Role of triggering receptor expressed on myeloid cells-1 (TREM-1) in COVID-19 and other viral pneumonias: a systematic review and meta-analysis of clinical studies Yrna Lorena Matos de Oliveira, Ayane de Sá Resende, Paulo Ricardo Martins-Filho, Tatiana Rodrigues de Moura
75 [GO] 2022―Mar―23 Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR Nourin Shakeeb, Prashanth Varkey, Aimy Hynse, Ajit Mandlecha
76 [GO] 2022―Mar―22 Comment on “Inflawell, neutrophil-to-lymphocyte ratio and COVID-19” Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
77 [GO] 2022―Mar―01 Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial Adel A. Gomaa, Hamdy S. Mohamed, Rasha B. Abd-ellatief, Mohamed A. Gomaa, Doaa S. Hammam
78 [GO] 2022―Feb―24 Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial Sepideh Barzin Tond, Laurent Balenci, Nasim Khajavirad, Mohammadreza Salehi, Abbas Tafakhori, Mohammad Reza Shahmohammadi, et al. (+13)
79 [GO] 2022―Feb―14 Selenium, selenoprotein P, and oxidative stress levels in SARS-CoV-2 patients during illness and recovery A. Skesters, D. Kustovs, A. Lece, E. Moreino, E. Petrosina, K. D. Rainsford
80 [GO] 2022―Jan―31 Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19 Parisa Feizollahi, Somaieh matin, Seyed Askar Roghani, Shayan Mostafaei, Elham Safarzadeh, Mahdi Taghadosi
81 [GO] 2022―Jan―31 The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis Chia Siang Chia Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
82 [GO] 2022―Jan―20 Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Suresh Sharma, Yogendra S. Padwad, Sanjay Kumar
83 [GO] 2022―Jan―03 Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination Rupinder Kaur, Shareen Singh, Thakur Gurjeet Singh, Pragati Sood, Jiki Robert
84 [GO] 2021―Dec―20 Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study Mahsa Mohajeri, Ehsan Horriatkhah, Reza Mohajery
85 [GO] 2021―Nov―25 NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown? Mina T. Kelleni
86 [GO] 2021―Oct―28 The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study Mahsa Mohajeri, Ehsan Horriatkhah, Reza Mohajery
87 [GO] 2021―Aug―09 Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Nahid Abbas, Prasad Sanjay Dhiwar, Abhishek Ghara, Arka Das
88 [GO] 2021―Jul―31 Recent updates on immunological, pharmacological, and alternative approaches to combat COVID-19 Ammara Saleem, Muhammad Furqan Akhtar, Muhammad Haris, Mohamed M. Abdel-Daim
89 [GO] 2021―Jul―19 COVID-19 vaccines and decreased transmission of SARS-CoV-2 A. Vitiello, F. Ferrara, V. Troiano, R. La Porta
90 [GO] 2021―Jul―09 SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism Ali Sepehrinezhad, Ali Gorji, Sajad Sahab Negah
91 [GO] 2021―Jul―05 Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly Adel A. Gomaa, Hamdy S. Mohamed, Rasha Bakheet Abd-ellatief, Mohamed A. Gomaa
92 [GO] 2021―Jun―29 Shedding light on vitamin D: the shared mechanistic and pathophysiological role between hypovitaminosis D and COVID-19 risk factors and complications Esraa Menshawey, Rahma Menshawey, Omnia Azmy Nabeh
93 [GO] 2021―Jun―10 Role of vitamins and minerals as immunity boosters in COVID-19 Puneet Kumar, Mandeep Kumar, Onkar Bedi, Manisha Gupta, Sachin Kumar, Gagandeep Jaiswal, et al. (+5)
94 [GO] 2021―May―03 Brief review of the mRNA vaccines COVID-19 Antonio Vitiello, Francesco Ferrara
95 [GO] 2021―Apr―21 The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis Chia Siang Kow, Syed Shahzad Hasan
96 [GO] 2021―Apr―06 Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection Menizibeya O. Welcome, Nikos E. Mastorakis
97 [GO] 2021―Mar―15 Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting Sreedhar Amere Subbarao
98 [GO] 2021―Feb―20 Correction to: COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties Muhammad Asif, Mohammad Saleem, Malik Saadullah, Hafiza Sidra Yaseen, Raghdaa Al Zarzour
99 [GO] 2020―Nov―16 COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials Desley Butters, Michael Whitehouse
100 [GO] 2020―Nov―07 The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients Apurva Hariharan, Abdul Rahman Hakeem, Subathra Radhakrishnan, Mettu Srinivas Reddy, Mohamed Rela
101 [GO] 2020―Sep―12 ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror Mina T. Kelleni
102 [GO] 2020―Aug―14 A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality Lucinda Smart, Neil Fawkes, Paul Goggin, Graham Pennick, K. D. Rainsford, Bruce Charlesworth, Neil Shah
103 [GO] 2020―Aug―14 COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties Muhammad Asif, Mohammad Saleem, Malik Saadullah, Hafiza Sidra Yaseen, Raghdaa Al Zarzour
104 [GO] 2020―Jul―07 A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms Kevin Roe
 [1] 

104 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.017 sec